Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?

Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?

Submitted by admin on March 28, 2023 - 10:46pm
Source: 
Motley Fool
News Tags: 
clinical trials
Bristol Myers Squibb
JNJ
milvexian
stroke
Headline: 
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
snippet: 
  • Milvexian is a drug candidate under development by Bristol Myers and Johnson & Johnson.
  • In a phase 2 clinical trial, milvexian produced encouraging results in preventing strokes.
  • If approved, it could generate several billion dollars in annual revenue for the two companies.

Do Not Allow Advertisers to Use My Personal information